Excitatory amino acid-induced toxicity in chick retina: amino acid release, histology, and effects of chloride channel blockers.

Journal of Neurochemistry
G D ZeevalkW J Nicklas

Abstract

Acute excitotoxicity in embryonic chick retina and the ability of Cl- channel blockers to prevent toxicity were evaluated by measurement of endogenous amino acid release and histology. Treatment of retina with kainate, quisqualate, or N-methyl-D-aspartate resulted in a large dose-dependent release of gamma-aminobutyric acid and taurine, moderate release of glutamine and alanine, and no measurable release of glutamate or aspartate. Concentrations inducing maximal gamma-aminobutyric acid release were 50 microM quisquaalate, 100 microM kainate, and 100 microM N-methyl-D-aspartate. Treatment with 1 mM glutamate resulted in significant gamma-aminobutyric acid release, as well as an elevation in medium aspartate levels. Typical excitotoxic retinal lesions were produced by the agonists and, at the lower concentrations tested, revealed a regional sensitivity. There was a positive correlation between the amount of gamma-aminobutyric acid release and the extent of tissue swelling, suggesting that release may be secondary to toxic cellular events. Omission of Cl- completely blocked cytotoxic effects due to kainate or glutamate. Likewise, addition of the Cl-/bicarbonate anion channel blocker 4,4'-diisothiocyanatostilbene-2,2'-disulfonate a...Continue Reading

References

Oct 1, 1976·General Pharmacology·M J Neal
Aug 22, 1987·The Journal of Comparative Neurology·S Catsicas, P G Clarke
Jan 1, 1986·Journal of Neuroscience Research·A M López-Colomé, F Somohano
Mar 28, 1986·Neuroscience Letters·J W OlneyJ Labruyere
Nov 8, 1986·Lancet·P S SpencerH H Schaumburg
Apr 1, 1987·Biochemical Society Transactions·W J NicklasA Hyndman
Aug 1, 1987·Neuroscience·S M RothmanR E Hauhart
Oct 1, 1967·Physiological Reviews·T H Maren
Feb 1, 1982·Journal of Neurochemistry·B KrespanW J Nicklas
Jul 20, 1982·The Journal of Comparative Neurology·D S CasperL Reif-Lehrer
Mar 14, 1983·Brain Research·S Yazulla, J Kleinschmidt
Apr 16, 1984·Brain Research·E W Wolpaw, D L Martin
Jul 1, 1984·Brain Research·B L Gibson, L Reif-Lehrer
Mar 21, 1980·European Journal of Pharmacology·W J NicklasS Berl
Sep 15, 1980·Brain Research·F J Seil, W R Woodward
Aug 1, 1957·A.M.A. Archives of Ophthalmology·D R LUCAS, J P NEWHOUSE

❮ Previous
Next ❯

Citations

Jan 5, 2005·Pflügers Archiv : European journal of physiology·L D Ochoa-de la PazH Pasantes-Morales
Nov 1, 1992·Neuropharmacology·A FleischmannA M Etgen
Feb 21, 1992·Brain Research. Developmental Brain Research·G D Zeevalk, W J Nicklas
Feb 10, 2004·Progress in Retinal and Eye Research·Neville N OsborneJosé Melena
Feb 26, 2003·European Journal of Pharmacology·Joseph S TauskelaPaul Morley
Jul 23, 1999·Survey of Ophthalmology·N N OsborneM S Nash
Mar 24, 1998·General Pharmacology·C B DuarteA P Carvalho
Oct 20, 1998·Progress in Retinal and Eye Research·C RomanoJ W Olney
Jul 17, 2001·The European Journal of Neuroscience·D Chesnoy-Marchais, L Cathala
Apr 1, 1997·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·T T LamM O Tso
Jan 1, 1990·The European Journal of Neuroscience·Anders Lehmann, Ingemar Jacobson
Oct 1, 1993·The European Journal of Neuroscience·A LehmannM Sandberg
Oct 1, 1993·Journal of Neurochemistry·G D Zeevalk, W J Nicklas
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·R GorovitsL Vardimon
Jul 3, 2002·Experimental Neurology·Gail D ZeevalkPatricia K Sonsalla
Apr 25, 2014·Pesticide Biochemistry and Physiology·Li-Jie ChenShu Li
Sep 1, 1996·Molecular and Chemical Neuropathology·G D Zeevalk, W J Nicklas
Sep 29, 2005·Acta Ophthalmologica Scandinavica·Andreas BringmannPeter Wiedemann
May 29, 2012·Acta Neurologica Scandinavica·M K Heim, B E Gidal
Mar 26, 2003·Brain Research·Shinji YonedaHideaki Hara
Apr 23, 2005·Progress in Retinal and Eye Research·Rafael LindenMariana S Silveira
Feb 7, 2006·Neuroscience Research·Min-Lin ChangChen-Yuan Wen
Sep 28, 2005·Experimental Eye Research·Shravan K Chintala
Jan 12, 2000·Experimental Neurology·Q ChenC Romano
Dec 19, 2001·Experimental Eye Research·S YonedaN Miyawaki
Sep 1, 1996·Vision Research·I M GoldsteinS Roth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.